Sunday Prep 9/12 - $ABUS Higher The Better! The higher the better on this name, but will be stalking it for lower highs and an area to get short with defined risk.
Key stats
Market capitalization
487.713MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.46USD
About Arbutus Biopharma Corporation
ISIN
CA03879J1003
Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
arbutusbio.com
CEO
William H. Collier
Headquarters
Warminster
Employees
98
Founded
2005
Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0